Board Member
Rhythm Pharmaceuticals, Inc. (RYTM)Board Member
Neogenomics Inc (NEO)Chairman
Neogenomics Inc (NEO)Equibles does not estimate personal net worth.
Get an email with a short summary when Rhythm Pharmaceuticals, Inc. publishes a filing, an earnings call transcript or a press release.
Get RYTM alertsLynn A. Tetrault is recorded as Board Member at Rhythm Pharmaceuticals, Inc. (RYTM), Board Member at Neogenomics Inc (NEO) since May 21, 2026 and Chairman at Neogenomics Inc (NEO) since March 28, 2022. The newest filing on record that lists Lynn A. Tetrault as Board Member at Rhythm Pharmaceuticals, Inc. (RYTM) is dated April 29, 2026. Neogenomics Inc reported in an 8-K filed May 22, 2026 that Lynn A. Tetrault was appointed member of the Board of Directors, effective May 21, 2026. Neogenomics Inc reported in an 8-K filed May 27, 2025 that Lynn A. Tetrault was appointed member of the Board of Directors, effective May 22, 2025. Neogenomics Inc is classified in the Diagnostics & Research industry within the Healthcare sector. Rhythm Pharmaceuticals, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Neogenomics Inc includes Chris Smith (CEO and Board Member), Christopher Smith (CEO and Board Member), Tony Zook (CEO, Chairman and Board Member) and 7 others.
“The election of Lynn A. Tetrault, Dr. Marjorie C. Green, Dr. Neil Gunn, Stephen M. Kanovsky, Michael A. Kelly, John P. Kenny, David B. Perez, Felicia Williams and Anthony P. Zook to serve as members of the Board of Directors until the next succeeding annual meeting of stockholders or until his or her successor has been duly elected and qualified.”
“The election of Lynn A. Tetrault, Elizabeth A. Floegel, Dr. Neil Gunn, Dr. Alison L. Hannah, Stephen M. Kanovsky, Michael A. Kelly, David B. Perez, Felicia Williams and Anthony P. Zook to serve as members of the Board of Directors until the next succeeding annual meeting of stockholders or until his or her successor has been duly elected and qualified.”
2026-05-21–present
2022-03-28–present
SEC 8-K
2020-07-15–present
Start not stated–present
Last confirmed April 29, 2026
NEO
Diagnostics & Research · Healthcare
Board Member, Chairman
2020-07-15–present
